G 343 (Oxybutynin chloride extended release 15 mg)
Pill imprint G 343 has been identified as Oxybutynin chloride extended release 15 mg.
Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; dysuria; hyperhidrosis; prostatitis and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for G 343 (Oxybutynin chloride extended release 15 mg)
- 15 mg
- 7.00 mm
- Rx and/or OTC
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- Inactive Ingredients:
|NDC Code||Manufacturer / Repackager|
|54868-5743||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about oxybutynin
- Oxybutynin extended-release tablets
- Oxybutynin gel
- Oxybutynin syrup
- Oxybutynin system
- More (4) »
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...